• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Adam and Dave Schechter a case of nepotism?

























Dave seriously you should stop taking this personally and be mature about the intent behind these anonymous posts. Obviously this is a sensitive topic which we cannot openly discuss.

You have to accept that you having been getting promotions, raises, stock options and opportunity as a preferential treatment because you are the brother of Adam, who is in charge of USHH. Your peers agree unanimously that you are condescending in your judgement, lazy, lack insights, intimidating, and incompetent to be in the current position.

Frankly, you are denying opportunities to other more qualified candidates.

That is what makes this a case of nepotism and that it is so unfair to your peers, your managers and a indeed a conflict which needs to be resolved. So please help further embarrassment to your brother and the company.

As a resolution, consider applying for a job in another company or becoming a handy man on Adam's Farm.

Surely by taking this action you will qualify for a good exit package.
 








Dave seriously you should stop taking this personally and be mature about the intent behind these anonymous posts. Obviously this is a sensitive topic which we cannot openly discuss.

You have to accept that you having been getting promotions, raises, stock options and opportunity as a preferential treatment because you are the brother of Adam, who is in charge of USHH. Your peers agree unanimously that you are condescending in your judgement, lazy, lack insights, intimidating, and incompetent to be in the current position.

Frankly, you are denying opportunities to other more qualified candidates.

That is what makes this a case of nepotism and that it is so unfair to your peers, your managers and a indeed a conflict which needs to be resolved. So please help further embarrassment to your brother and the company.

As a resolution, consider applying for a job in another company or becoming a handy man on Adam's Farm.

Surely by taking this action you will qualify for a good exit package.

I know and work with Dave and he really sucks. Surrounded by a circle of cronies preventing progress.
 




Nepotisim is easy to prove with facts and background search.

To associate a conflict and preferential treatment for Dave and his cronies, get someone in HR to examine Dave's promotional raises, ratings and compensation over the past 10 years and do the same for all his managers.

With confidence the evidence will show both Dave and manager's over time received significant inflation in their salary increases and overall compensation.

That is the travesty!
 
























Hello Merckites so lets list how does nepotism work and creates collateral damage for other employees when dealing with the wonderful brothers?

So brother Dave gets all the good jobs and promotions within brother Adam's empire....certainly not professional in a public traded company.

Brother Dave has job security and is protected when other employees are getting the boot....speak up and you will get hacked.

Brother Dave gets more higher merit raises and MRK options....stealing from others.

Brother Dave is never challenged since he is a protected species....not fair balanced.

Brother Dave is never held accountable for any of his actions....so unfair and intimidating.

Brother Dave reports to brother Adam about employees....adding to a culture self doubt and creating unnecessary anxiety.

Both brothers have added to a culture of creating favoritism and cronyism....a culture lacking merit based performance.



Merkites any other thoughts to share about these wonderful brothers?

Brother Dave is doing a terrific job I gave him all the necessary resources from his peers who were not performing....it worked. Keep it up brother.

Merck has been spending heavily on marketing DPP-4 inhibitor Januvia, and thus far it's been working. Sales of the drug were up 10% in the third quarter from the prior-year period, and 17% on an operational basis. But the emergence of SGLT-2 inhibitors creates a challenge.
 




Brother Dave is doing a terrific job I gave him all the necessary resources from his peers who were not performing....it worked. Keep it up brother.

Merck has been spending heavily on marketing DPP-4 inhibitor Januvia, and thus far it's been working. Sales of the drug were up 10% in the third quarter from the prior-year period, and 17% on an operational basis. But the emergence of SGLT-2 inhibitors creates a challenge.
So finally the bubbles bursts on Januvia franchise, the brother to brother strategy crashes. So time to go into the 'Spin Zone'.
"Sales of Januvia and a related drug called Janumet, the company's biggest franchise, fell 12 percent to $1.45 billion. Merck said their tumble was due in large part to timing of customer purchases in the third quarter. Competition from a growing number of other oral diabetes treatments also hurt sales".
 




Brother Dave is doing a terrific job I gave him all the necessary resources from his peers who were not performing....it worked. Keep it up brother.

Merck has been spending heavily on marketing DPP-4 inhibitor Januvia, and thus far it's been working. Sales of the drug were up 10% in the third quarter from the prior-year period, and 17% on an operational basis. But the emergence of SGLT-2 inhibitors creates a challenge.

Finally Dave and his Januvia team woke up and have launched newly focused DTC ads to reverse and stop SGLT-2 share gains.
 








Merck could save $10 Million a year by letting go of these two brothers and hiring 50 mangers who understand people, health care and implementation to turn this company around. Such a pathetic place to work.